Speciality: Oncology
Description:
Welcome to our special feature on relapsed B-cell Acute Lymphoblastic Leukemia (B-cell ALL) in adults. Join leading experts Dr. Riyaz Ahmad, Dr. Nitin Gupta, and Dr. Eesha Kaul as they explore the latest breakthroughs in treating this aggressive form of leukemia. With years of experience in hematology and oncology, they bring valuable insights into how modern medicine is reshaping the outlook for adult patients.
In this video, our experts discuss the challenges of relapsed B-cell ALL and how innovative treatments like CAR T-cell therapy, blinatumomab, and inotuzumab ozogamicin are offering new hope. They highlight the importance of precision medicine, the evolving role of stem cell transplantation, and the need for holistic care in improving outcomes and quality of life for patients.
Thank you for watching. We hope this video offers clarity and encouragement to patients, families, and healthcare professionals. Don’t forget to like, share, and follow our channel for more updates on cutting-edge treatments and expert perspectives in cancer care.
See More Webinars @ Hidoc Webinars
1.
How wildfires pose challenges to cancer care
2.
New policy review highlights the importance of health-related quality of life in advanced cancer
3.
ASCO Expert Roundtable: Breast Cancer: Expert Roundtable from the American Society of Clinical Oncology
4.
Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries
5.
The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.
1.
Evidence-Based Pathways for Survivorship Care Planning
2.
Managing Acute Respiratory Failure in Hematological Malignancies
3.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
Integrated Frameworks in Hematology in Clinical Decision-Making
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation